Abstract:BACKGROUND:Pancreatic cancer is a common malignant tumor of the digestive system. It is the fourth major cause of tumor-related death and its morbidity is increasing, and hence it is imperative to develop effective forms of therapy for pancreatic cancer. Peptide tyrosine-tyrosine (PYY) is an important gastrointestinal peptide hormone. According to previous literatures, PYY has been shown to inhibit tumor proliferation in cellular and animal models, but there has been limited research on the detailed mechanism of PYY in pancreatic cancer. This study was to observe the effects of PYY on pancreatic cancer cell and investigate the possible mechanism.METHODS:The expression of Y1, Y2, and Y5 receptors on pancreatic cancer cell lines were detected by reverse transcription quantitative polymerase chain reaction (RT-qPCR). The cytotoxicity of PYY toward the MiaPaCa-2 cell was evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay; the cell morphology and structure changes were observed under inverted microscope and transmission electron microscope respectively. Apoptosis and cell cycle were evaluated by flow cytometry. The activity of caspase-3 was determined by activity assay kits and Western blotting. The expression of survivin, vascular endothelial growth factor (VEGF), and cyclooxygenase-2 (COX-2) were determined by RT-qPCR and Western blotting.RESULTS:Expression of Y2 receptor is the most abundant PYY receptor on pancreatic cancer cell. PYY inhibited MiaPaCa-2 cell proliferation, blocked it in G0/G1 phase, increased the proportion of apoptosis cells and caspase-3 activity, and reduced the expression of survivin, VEGF, and COX-2.CONCLUSIONS:PYY weakened the ability of the pancreatic MiaPaCa-2 cell viability through cell cycle blocking and apoptosis inducing. The inhibition effect of PYY may be mediated by the Y2 receptor. The increased caspase-3 activity and reduced expression of survivin, VEGF, and COX-2 may serve as a novel mechanism in PYY inhibition effect on MiaPaCa-2 cell.

Pseudomonas Aeruginosa-Mannose-sensitive Hemagglutinin Inhibits Pancreatic Cancer Cell Proliferation and Induces Apoptosis Via the EGFR Pathway and Caspase Signaling

Pseudomonas Aeruginosa-Mannose-Sensitive Hemagglutinin Inhibits Proliferation And Induces Apoptosis In A Caspase-Dependent Manner In Human Bladder Cancer Cell Lines

Pseudomonas Aeruginosa-Mannose–sensitive Hemagglutinin Inhibits Epidermal Growth Factor Receptor Signaling Pathway Activation and Induces Apoptosis in Bladder Cancer Cells in Vitro and in Vivo

0015 PA-MSHA Inhibits Proliferation and Induces Apoptosis Through the Up-Regulation and Activation of Caspases in the Human Breast Cancer Cell Lines

Inhibition of EGFR pathway signaling and the metastatic potential of breast cancer cells by PA-MSHA mediated by type 1 fimbriae via a mannose-dependent manner.

PA-MSHA Inhibits Proliferation and Induces Apoptosis in Human Non-Small Cell Lung Cancer Cell Lines with Different Genotypes.

Therapeutic potential of<i> Pseudomonas</i><i> aeruginosa-mannose</i> sensitive hemagglutinin (PA-MSHA) in cancer treatment

Anti-proliferative effect of pseudomonas aeruginosa-manno sesensitive hemagglutinin on T24 and 5637 bladder cancer cell line

Inhibitory Effects of Pseudomonas Aeruginosa Mannose-Sensitive Hemagglutinin on Rat C6 Glioma Cell Proliferation

Study on anti-cancer effects of pseudomonas aeruginosa for pancreatic cancer cells and molecular mechanism

PA-MSHA Induces Inflamed Tumor Microenvironment and Sensitizes Tumor to Anti-Pd-1 Therapy

PA-MSHA Regulates PD-L1 Expression in Hepatoma Cells

Pseudomonas Aeruginosa Mannose-Sensitive Hemagglutinin Promotes T-cell Response Via Toll-Like Receptor 4-Mediated Dendritic Cells to Slow Tumor Progression in Mice.

Inhibition of P21 Activated Kinase Enhances Tumour Immune Response and Sensitizes Pancreatic Cancer to Gemcitabine

PAK Inhibition by PF-3758309 Enhanced the Sensitivity of Multiple Chemotherapeutic Reagents in Patient-Derived Pancreatic Cancer Cell Lines.

The PAK Inhibitor PF-3758309 Promotes the Inhibitory Effects of Multiple Chemotherapeutic Reagents on Patient-Derived Pancreatic Cancer Cell Lines

The Mechanism of Pseudomonasaeruginosa Mannose Sensitive Hamemagglutination Vaccine in Inducing Apoptosis of Hepatocellular Carcinoma

Peptide Tyrosine-Tyrosine Combined with Its Receptors Exhibits an Anti-Cancer Potential in Pancreatic Cancer Miapaca-2 Cell

PA-MSHA exerts potent activity against cetuximab-resistant colorectal cancer through miR-7-5p/Akt/Wnt-β-catenin pathway

Pa-Msha In Combination With Egfr Tyrosine Kinase Inhibitor: A New Strategy To Overcome The Drug Resistance Of Non-Small Cell Lung Cancer Cells

Trends in Anti-Tumor Effects of Pseudomonas aeruginosa Mannose-Sensitive-Hemagglutinin (PA-MSHA): An Overview of Positive and Negative Effects